QTTB Q32 Bio Inc.

NASDAQ
$16.32

Q32 Bio Inc. (QTTB) Institutional Ownership

What the institutions did with QTTB last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
79
filed a 13F this quarter
Managers holding
71
+19 on the quarter
Buyers
45
27 opened new
Sellers
21
8 sold out entirely
Buyer share
68.2%
of managers who traded it
Breadth
+36.4
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
ORBIMED ADVISORS LLC 4.1M 18.6%
Boxer Capital Management, LLC 3.1M 14.2%
Atlas Venture Life Science Advisors, LLC 2.7M 12.2%
BVF INC/IL 2.4M 10.6%
RA CAPITAL MANAGEMENT, L.P. 2.3M 10.5%
Point72 Asset Management, L.P. 1.2M 5.3%
Opaleye Management Inc. 931.0K 4.2%
Logos Global Management LP 800.0K 3.6%
SummitTX Capital, L.P. 733.8K 3.3%
VANGUARD CAPITAL MANAGEMENT LLC 518.8K 2.3%
Ikarian Capital, LLC 430.0K 1.9%
Woodline Partners LP 286.2K 1.3%
AMERICAN CENTURY COMPANIES INC 272.8K 1.2%
Sanofi 244.1K 1.1%
ACADIAN ASSET MANAGEMENT LLC 218.2K 1.0%
ACORN CAPITAL ADVISORS, LLC 216.2K 1.0%
RENAISSANCE TECHNOLOGIES LLC 179.6K 0.8%
JANE STREET GROUP, LLC 162.7K 0.7%
MONIMUS CAPITAL MANAGEMENT, LP 132.0K 0.6%
BOOTHBAY FUND MANAGEMENT, LLC 130.4K 0.6%
GEODE CAPITAL MANAGEMENT, LLC 122.7K 0.6%
CITADEL ADVISORS LLC 120.7K 0.5%
BlackRock, Inc. 118.5K 0.5%
MARSHALL WACE, LLP 67.0K 0.3%
VANGUARD FIDUCIARY TRUST CO 66.2K 0.3%

Largest changes

Manager Action Previous Current Change
Boxer Capital Management, LLC New 0 3.1M +3.1M
BVF INC/IL New 0 2.4M +2.4M
RA CAPITAL MANAGEMENT, L.P. New 0 2.3M +2.3M
ORBIMED ADVISORS LLC Increased 2.3M 4.1M +1.9M
Point72 Asset Management, L.P. New 0 1.2M +1.2M
Carlyle Group Inc. Reduced 1.1M 60.4K -1.0M
Logos Global Management LP New 0 800.0K +800.0K
SummitTX Capital, L.P. New 0 733.8K +733.8K
Atlas Venture Life Science Advisors, LLC Increased 2.1M 2.7M +625.0K
Ikarian Capital, LLC New 0 430.0K +430.0K
Opaleye Management Inc. Reduced 1.3M 931.0K -325.2K
ARCH Venture Management, LLC Sold Out 320.5K 0 -320.5K
Woodline Partners LP New 0 286.2K +286.2K
AMERICAN CENTURY COMPANIES INC Increased 18.8K 272.8K +254.0K
MACKENZIE FINANCIAL CORP Sold Out 246.3K 0 -246.3K
VANGUARD CAPITAL MANAGEMENT LLC Increased 306.4K 518.8K +212.4K
BOOTHBAY FUND MANAGEMENT, LLC New 0 130.4K +130.4K
CITADEL ADVISORS LLC Increased 15.5K 120.7K +105.2K
Pfizer Inc Sold Out 101.6K 0 -101.6K
ACORN CAPITAL ADVISORS, LLC Reduced 315.1K 216.2K -98.9K
JANE STREET GROUP, LLC Increased 65.6K 162.7K +97.1K
ACADIAN ASSET MANAGEMENT LLC Increased 172.6K 218.2K +45.6K
Quadrature Capital Ltd New 0 36.4K +36.4K
ADAR1 Capital Management, LLC Sold Out 35.0K 0 -35.0K
DAFNA Capital Management LLC New 0 32.9K +32.9K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.